3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
12
Breast Neoplasms
12
Pain
11
Neoplasms
10
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
6
Agnosia
6
Colonic Neoplasms
5
Neuralgia
4
Keratosis, Actinic
4
Cancer Pain
4
Liver Neoplasms
3
Leiomyoma
3
Head and Neck Neoplasms
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Paclitaxel
10
Surveys and Questionnaires
6
Cisplatin
6
Carboplatin
5
pembrolizumab
4
Brachytherapy
4
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
Doxorubicin
3
Docetaxel
3
olaparib
2
niraparib
2
durvalumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Music Therapy
2
Mitomycin
2
Letrozole
2
Imagery, Psychotherapy
2
Hysterectomy
2
Exercise
2
Everolimus
2
Blood Specimen Collection
2
ulipristal acetate
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Neoplasms
×
Lidocaine
×
Clear all
NCT01492179
2014-05-28
PoPuLAR
Örebro University, Sweden
Phase 4
Completed
60 enrolled